Cyclodextrin and KR12-Lipopeptide Interactions
Natural antimicrobial peptides are a promising new class of antibiotics that offer a potential response to the growing challenge of
EURO CD 2019 Abstract submission
The 6th European Cyclodextrin Conference will be held in Santiago de Compostela between October 2–4, 2019. Abstract submission period will
Molecules, Special issue “Cyclodextrin Chemistry 2018” deadline for manuscript submission is coming soon
The open-access journal Molecules with Bernard Martel as guest editor has started to publish the papers in the special issue
Gordon Research Conference: Artificial Molecular Switches and Motors
The conference on Molecular Machines in Solution, Soft Matter and Solid State Materials will be held on June 9–14, 2019
CycloPure Completes $5 Million Fundraising Proceeds to Accelerate Commercialization of Products
CycloPure, Inc., a leading innovator in water purification technologies and the developer of DEXSORB™ filtration products, announced it has raised
CTD Reports Initial Data for Two Clinical Trials of Trappsol® Cyclo™
CTD Holdings, Inc., a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical
Future automobiles made from supramolecular polymers are reality?
Professor Ito Kohzo and his team at the University of Tokyo, developed novel, so–called sliding gel polymers that comprises a
CDs in hydrogen storage
Hydrogen as clean and renewable energy source could replace fossil fuels, but the lack of method for efficient storage inhibits
Cyclodextrins in veterinary medicine (Part 2)
In our previous post we talked about the “classical” usage of cyclodextrins in veterinary medicine. Now let’s see some non-usual
CDs in biodegradation-based soil remediation under aerobic conditions
The non-toxic, biodegradable cyclodextrins (CDs) can solubilize poorly soluble organic contaminants such as PAHs, PCBs, chlorinated solvents, etc. via molecular
CTD Announces Partnership with United BioSource
CTD Holdings, a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need,